Today, XtalPi, a leading global technology company in combining artificial intelligence (AI) and robotics to drive the discovery of groundbreaking medicine and innovative materials, announced the signing of a new agreement with CK Life Sciences, a member of the CK Hutchison Group. Expanding upon their existing partnership, the two companies will combine AI algorithms with anonymized clinical and biomarker data from cancer patients and healthy individuals in CK Life Sciences' data repository to j
<p>HONG KONG SAR - <a href="https://www.media-outreach.com/">Media OutReach</a> - 1 November 2023 - CK Life Sciences Int l., (Holdings) Inc. is presenting preclinical data for its investigational dual-antigen cancer vaccines, co-targeting PRAME (preferentially expressed antigen in melanoma) and PD-L1 (programmed death-ligand 1), on November 4<b> </b>at the 2023 Society for Immunotherapy of Cancer (SITC) Annual Meeting in San Diego, California, USA.</p>